Workflow
Shoals Technologies (SHLS) - 2025 Q4 - Earnings Call Presentation
2026-02-24 13:00
Non-GAAP Financial Information All results shared within this presentation are non-GAAP unless noted as "reported," in which case we are referring to our results on a GAAP basis. Please see GAAP to non-GAAP reconciliations at the end of this presentation for comparable GAAP measures. Refer to the definitions of these measures in our earnings release for Q4 2025 on our investor relations website at https://investors.shoals.com. Market and Industry Data This presentation also contains information regarding th ...
AxoGen(AXGN) - 2025 Q4 - Earnings Call Presentation
2026-02-24 13:00
Q4 and 2025 Financial Results February 24, 2026 1 Disclaimer Forward-looking Statements This presentation contains "forward-looking" statements as defined in the Private Securities Litigation Reform Act of 1995, which are statements that are not historical facts and relate to future conditions, events, or results. These statements are based on management's current expectations or predictions of future conditions, events, or results based on various assumptions and management's estimates of trends and econom ...
DigitalOcean(DOCN) - 2025 Q4 - Earnings Call Presentation
2026-02-24 13:00
Q4 2025 Earnings and Investor Update Presentation February 24, 2026 2026 DigitalOcean. All rights reserved 1 Safe Harbor This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements regarding our financial outlook. These statements are subject to known and unknown risks, uncertainties, assumptions, and other factors that may cause actual results or ou ...
Quaker(KWR) - 2025 Q4 - Earnings Call Presentation
2026-02-24 13:00
Quaker Houghton Fourth Quarter and Full Year 2025 Results Investor Conference Call Forward-Looking Statements Forward-Looking Statements This presentation contains "forward-looking statements" that fall under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and the Securities Act of 1933, as amended. These statements can be identified by the fact that they do not relate strictly to historical or current facts. We have based these forward-looking statements on assumptions, p ...
Henry Schein(HSIC) - 2025 Q4 - Earnings Call Presentation
2026-02-24 13:00
Q4 2025 Earnings Conference Call Financial Results & Outlook February 24, 2026 1 Cautionary Note Regarding Forward-Looking Statements and Use of Non-GAAP Financial Information In accordance with the "Safe Harbor" provisions of the Private Securities Litigation Reform Act of 1995, we provide the following cautionary remarks regarding important factors that, among others, could cause future results to differ materially from the forward-looking statements, expectations and assumptions expressed or implied here ...
Super Group(SGHC) - 2025 Q4 - Earnings Call Presentation
2026-02-24 13:00
4Q 2025 Earnings Review February 23, 2026 DISCLAIMERS Forward-Looking Statements Certain statements made in this presentation are "forward looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, Super Group's intention to pay a dividend, including the expected timing of such dividend, expectations and projections of market opportunity, growth and profitabili ...
Vir Biotechnology (NasdaqGS:VIR) Earnings Call Presentation
2026-02-24 12:00
Corporate Overview Presentation February 2026 2026 Vir Biotechnology, Inc. 1 Legal disclaimer Forward-Looking Statements Statements in this presentation that are not statements of historical fact are forward-looking statements. Such forward-looking statements include, without limitation, statements regarding: the therapeutic and commercial potential of Vir Biotechnology's CHD program, as well as Vir Biotechnology's strategy, plans and expectations related thereto; the therapeutic and commercial potential of ...
Standard Chartered (SEHK:02888) Earnings Call Presentation
2026-02-24 12:00
Standard Chartered Investor overview February 2026 Standard Chartered history spans over 170 years We operate in the world's most dynamic markets Present in 54 markets; using the power of our network to maximise opportunities for people and businesses who trade, operate, or invest across our markets. Our diverse experience, capabilities and culture set us apart Our locations Europe and America Our Americas franchise is focused on CIB business, and our London headquarters also services our Private Bank clien ...
Diversified Healthcare Trust (NasdaqGS:DHC) Earnings Call Presentation
2026-02-24 12:00
Investor Presentation February 2026 1 1 Overture at Plano 500 Coit Road Plano, TX Warning Concerning Forward Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other securities laws that are subject to risks and uncertainties. These statements may include words such as "believe", "expect", "anticipate", "intend", "plan", "estimate", "will", "may" and negatives or derivatives of these or similar expressions. ...
Iovance Biotherapeutics (NasdaqGM:IOVA) Earnings Call Presentation
2026-02-24 12:00
Corporate Overview February 2026 © 2026, Iovance Biotherapeutics, Inc. © 2026, Iovance Biotherapeutics, Inc. 1 Forward-Looking Statements Certain matters discussed in this presentation are "forward-looking statements" of Iovance Biotherapeutics, Inc. (hereinafter referred to as the "Company," "we," "us," or "our") within the meaning of the Private Securities Litigation Reform Act of 1995 (the "PSLRA"). Without limiting the foregoing, we may, in some cases, use terms such as "predicts," "believes," "potentia ...